Vaxxinity Inc - Ordinary Shares - Class A

Controls taxation, trade, and entitlement spending (e.g., Medicare, Medicaid). Tax policy directly impacts Vaxxinity's profitability, and decisions regarding Medicare/Medicaid coverage and pricing are critical for the commercial viability of its vaccines.

Directly allocates federal discretionary spending. Subcommittees determine the precise funding levels for agencies such as the NIH, CDC, BARDA, and FDA, which are critical for Vaxxinity's research funding, regulatory environment, and potential procurement contracts.

Directly oversees the FDA (responsible for vaccine approval) and the NIH (major funder of biomedical research). Committee members would possess direct insight into regulatory pathways and funding priorities crucial for Vaxxinity's success.